Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Menopause01:28

Menopause

Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
Hormonal Regulation of the Menstrual Cycle01:22

Hormonal Regulation of the Menstrual Cycle

The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Non-metastatic breast cancer patients discontinuing aromatase inhibitor on denosumab: what next?

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2026
Same author

Bone quality in endocrine diseases: determinants and clinical relevance.

Journal of endocrinological investigation·2023
Same author

Structure and size-dependent vibrational and thermal properties of Ni clusters: A systematic ab initio approach.

Journal of molecular graphics & modelling·2023
Same author

The Impact of Diet on Bone and Fracture Risk in Diabetes.

Current osteoporosis reports·2022
Same author

Synthesis and characterization of a bovine collagen: GAG scaffold with Uruguayan raw material for tissue engineering.

Cell and tissue banking·2021
Same author

Secondary prevention of fragility fractures: where do we stand during the COVID-19 pandemic?

Journal of endocrinological investigation·2021

Related Experiment Video

Updated: Jul 15, 2026

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats
08:56

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats

Published on: April 7, 2023

Estrogen metabolism modulates bone density in men.

N Napoli1, R Faccio, V Shrestha

  • 1Division of Bone and Mineral Diseases, Washington University School of Medicine, 660 South Euclid Avenue, St. Louis, MO 63110, USA. nnapoli@im.wustl.edu

Calcified Tissue International
|April 5, 2007
PubMed
Summary

Estrogen metabolism impacts bone mineral density (BMD) in men. Higher levels of active estrogen metabolites, like 16alpha-hydroxyestrone, are linked to increased proximal femur BMD, suggesting a key role in male bone health.

Related Experiment Videos

Last Updated: Jul 15, 2026

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats
08:56

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats

Published on: April 7, 2023

Area of Science:

  • Endocrinology
  • Bone Biology
  • Metabolomics

Background:

  • Estrogen is crucial for bone homeostasis in men, yet its metabolism's role in male bone health is understudied.
  • Understanding estrogen metabolism pathways is vital for addressing bone health in aging males.

Purpose of the Study:

  • To investigate the association between estrogen hydroxylation metabolites and bone mineral density (BMD) in healthy Caucasian males.
  • To identify specific estrogen metabolites that may predict or influence male BMD.

Main Methods:

  • Assessed urinary estrogen metabolites (16alpha-hydroxyestrone, estriol, 2-hydroxyestrone, 2-methoxyestrone) using ELISA.
  • Measured serum estradiol and sex hormone-binding globulin via radioimmunoassay.
  • Quantified BMD at the lumbar spine and proximal femur using dual-energy X-ray absorptiometry in 61 healthy males.

Main Results:

  • Active metabolites 16alpha-hydroxyestrone (16alphaOHE(1)) and estriol (E(3)) positively correlated with proximal femur BMD (P < 0.05).
  • The Free Estradiol Index (FEI) also showed positive correlations with hip, femoral neck, and intertrochanteric BMD (P < 0.05).
  • 16alphaOHE(1), FEI, and BMI were identified as independent predictors of proximal femur BMD via multiple regression analysis.

Conclusions:

  • Estrogen metabolism significantly modulates bone mineral density in men.
  • Elevated urinary 16alphaOHE(1) and E(3) levels are associated with higher proximal femur BMD.
  • 16alpha-hydroxyestrone emerges as a key determinant of BMD among evaluated estrogen metabolites in men.